Risk of Hypersensitivity to Biologic Agents Among Medicare Patients With Rheumatoid Arthritis

ConclusionAmong RA patients taking biologic agents, rituximab and infliximab were most strongly associated with HSRs. The absolute IRs of HSR events for all biologic agent exposures were low.

Source: Arthritis Care and Research - September 27, 2017 Category: Rheumatology Authors: Huifeng Yun, Fenglong Xie, Randall N. Beyl, Lang Chen, James D. Lewis, Kenneth G. Saag, Jeffrey R. Curtis Tags: Rheumatoid Arthritis Source Type: research